中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2010年
12期
949-951
,共3页
马晋平%彭林%赵刚%蔡世荣%陈创奇%胡世雄%吴恺明%韩方海%何裕隆%詹文华
馬晉平%彭林%趙剛%蔡世榮%陳創奇%鬍世雄%吳愷明%韓方海%何裕隆%詹文華
마진평%팽림%조강%채세영%진창기%호세웅%오개명%한방해%하유륭%첨문화
胰腺切除术%脾%胰腺疾病
胰腺切除術%脾%胰腺疾病
이선절제술%비%이선질병
Pancreatectomy%Spleen%Pancreatic diseases
目的 总结保留脾血管的保留脾脏胰体尾切除术的临床应用经验.方法 回顾性分析中山大学附属第一医院胃肠胰腺外科和广东省人民医院普通外科2002年5月至2009年4月间施行的26例胰体尾切除手术,其中选择保留脾脏组13例,切除脾脏组13例.比较两组的手术时间,术中出血量,术后感染与非感染并发症,术后血小板计数及术后住院时间等情况.结果 保留脾脏组和切除脾脏组在手术时间[(172±47)min比(157±52)min,P＞0.05],术中出血量[(183±68)ml比(160±51)ml,P＞0.05],术后并发症和术后住院时间等差异无统计学意义[(10.1±2.2)d比(12.1±4.6)d,P＞0.05];而术后血小板计数差异有统计学意义[(37.3±12.8)×109/L比(54.7±13.2)×109/L,P＜0.05].结论 保留脾脏的胰体尾切除手术治疗胰腺良性或低度恶性肿瘤是可行、安全的.
目的 總結保留脾血管的保留脾髒胰體尾切除術的臨床應用經驗.方法 迴顧性分析中山大學附屬第一醫院胃腸胰腺外科和廣東省人民醫院普通外科2002年5月至2009年4月間施行的26例胰體尾切除手術,其中選擇保留脾髒組13例,切除脾髒組13例.比較兩組的手術時間,術中齣血量,術後感染與非感染併髮癥,術後血小闆計數及術後住院時間等情況.結果 保留脾髒組和切除脾髒組在手術時間[(172±47)min比(157±52)min,P＞0.05],術中齣血量[(183±68)ml比(160±51)ml,P＞0.05],術後併髮癥和術後住院時間等差異無統計學意義[(10.1±2.2)d比(12.1±4.6)d,P＞0.05];而術後血小闆計數差異有統計學意義[(37.3±12.8)×109/L比(54.7±13.2)×109/L,P＜0.05].結論 保留脾髒的胰體尾切除手術治療胰腺良性或低度噁性腫瘤是可行、安全的.
목적 총결보류비혈관적보류비장이체미절제술적림상응용경험.방법 회고성분석중산대학부속제일의원위장이선외과화광동성인민의원보통외과2002년5월지2009년4월간시행적26례이체미절제수술,기중선택보류비장조13례,절제비장조13례.비교량조적수술시간,술중출혈량,술후감염여비감염병발증,술후혈소판계수급술후주원시간등정황.결과 보류비장조화절제비장조재수술시간[(172±47)min비(157±52)min,P＞0.05],술중출혈량[(183±68)ml비(160±51)ml,P＞0.05],술후병발증화술후주원시간등차이무통계학의의[(10.1±2.2)d비(12.1±4.6)d,P＞0.05];이술후혈소판계수차이유통계학의의[(37.3±12.8)×109/L비(54.7±13.2)×109/L,P＜0.05].결론 보류비장적이체미절제수술치료이선량성혹저도악성종류시가행、안전적.
Objective To study the feasibility, safety and clinical effects of spleen and splenic vessel-preserving distal pancreatectomy. Methods A retrospective study was performed in 26 patients undergoing distal pancreatectomy for benign or low grade malignant disease with splenectomy (n = 13) or splenic preservation (n = 13 ) at the First Hospital of Sun Yat-sen University and Guangdong General Hospital from May 2002 to April 2009. Results All 26 pancreatectomy with splenectomy or splenic preservation were performed successfully. There was no statistically significant difference between two groups in average operative time[(172±47) min vs. (157±52) min, P ＞ 0.05 ], intraoperative estimated blood loss [( 183 ± 68 ) ml vs. ( 160 ± 51 ) ml, P ＞ 0.05 ], incidence of noninfectious and infection complication and postoperative hospital stay [(10.1±2.2) d vs. ( 12. 1 ± 4. 6 ) d, P ＞ 0.05 ]. The platelet counts examined one week after operation were significantly higher in the distal pancreatectomy with splenectomy group than that in spleen-preserving group [(37.3 ± 12.8)×109/L vs. (54.7 ± 13.2) × 109/L, P＜0.05 ]. Conclusions Spleen-preserving distal pancreatectomy appears to be a feasible and safe procedure in selected cases of benign or low-grade pancreatic malignant disease necessitating a distal pancreatectomy.
